Xortx Therapeutics Stock Target Price
| XRTX Stock | USD 1.01 0.04 3.81% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess XORTX Therapeutics' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
XORTX Fundamentals
| Return On Equity | -0.83 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 1.36 M | ||||
| Shares Outstanding | 3.79 M | ||||
| Shares Owned By Insiders | 3.51 % | ||||
| Shares Owned By Institutions | 7.57 % | ||||
| Number Of Shares Shorted | 31.45 K | ||||
| Price To Earning | 170.67 X | ||||
| Price To Book | 1.15 X | ||||
| EBITDA | (4.87 M) | ||||
| Net Income | (2.16 M) | ||||
| Cash And Equivalents | 13.42 M | ||||
| Cash Per Share | 1.03 X | ||||
| Total Debt | 11.51 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.09 X | ||||
| Book Value Per Share | 0.96 X | ||||
| Cash Flow From Operations | (6.58 M) | ||||
| Short Ratio | 1.91 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Price To Earnings To Growth | 9.08 X | ||||
| Target Price | 14.5 | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 3.83 M | ||||
| Total Asset | 5.47 M | ||||
| Retained Earnings | (23.66 M) | ||||
| Working Capital | 3.77 M | ||||
| Current Asset | 341.74 M | ||||
| Current Liabilities | 109.37 M | ||||
| Net Asset | 5.47 M |
About XORTX Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XORTX Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XORTX Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XORTX Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.